Clinical Edge Journal Scan

Phytochemical and polyphenol rich diet reduces migraine severity


 

Key clinical point: High quality diet and higher total intake of phytochemicals and polyphenols are significantly associated with lower migraine severity in patients with episodic migraine.

Major finding: Migraine severity was negatively correlated with the intake of good quality diet (correlation coefficient [r] 0.37; P = .0003) and higher intake of phytochemicals (r 0.37; P = .0003) and phenolic components, such as flavanones (r 0.27; P = .01) and lignans (r 0.27; P = .01). The total intake of phenols and flavonoids from olive oil, oil, and fruits was also significantly negatively correlated with migraine severity (each P .04).

Study details: This questionnaire-based study included 90 patients with episodic migraine who were assessed for their migraine characteristics and dietary phytochemical and polyphenol intake.

Disclosures: This study did not report the source of funding. The authors declared no conflicts of interest.

Source: Bakırhan H et al. Migraine severity, disability, and duration: Is a good diet quality, high intake of phytochemicals and polyphenols important? Front Nutr. 2022;9:1041907 (Nov 21). Doi: 10.3389/fnut.2022.1041907

Recommended Reading

Galcanezumab reduces migraine severity and symptoms in episodic migraine
Migraine ICYMI
Migraine in children and teens: managing the pain
Migraine ICYMI
Commentary: Risk factors and treatment for pediatric migraine, December 2022
Migraine ICYMI
High drug costs exclude most neurology patients from cutting-edge treatment
Migraine ICYMI
Evidence supporting atogepant as a promising treatment for migraine prevention
Migraine ICYMI
Alcohol as a trigger for migraine: What is the link?
Migraine ICYMI
Prior proton-pump inhibitor use ups migraine risk
Migraine ICYMI
Some patients with resistant chronic migraine may derive long-term benefits with erenumab
Migraine ICYMI
Migraine: Erenumab demonstrates superior efficacy over topiramate
Migraine ICYMI
Real world tolerability of onabotulinum toxin A in chronic migraine
Migraine ICYMI